Skip to Content


Home > North America > USA > HepaLife Technologies Inc.

< Previous | Next >

HepaLife Technologies Inc. (Visit their Website)



Company Information

• Country: USA
• State or province: MA
• Zip, postal code: 02109
• Telephone: 800-518-4879
• Street Address: 60 State St., Suite 700, Boston
• Ceo, President: Frank Menzler

Summary

HepaLife is working towards the first-of-its-kind bioartificial liver device for acute liver failure using the company’s patented PICM-19 liver stem cell line. The HepaLife bioartificial liver, currently under development, is designed to serve as a supportive device, either allowing the liver to regenerate upon acute liver failure, or to bridge the patient’s liver functions until a transplant is available.
Visit HepaLife Technologies Inc..

Description (Web site quote)

Utilizing its patented liver stem cell line PICM-19, HepaLife is designing testing platforms to improve the pharmaceutical industry's capability to evaluate drug toxicity and possible side-effects before pharmaceutical compounds are commercially distributed.


Visit HepaLife Technologies Inc..

HepaLife is working towards the first-of-its-kind bioartificial liver device for acute liver failure using the company’s patented PICM-19 liver stem cell line. The HepaLife bioartificial liver, currently under development, is designed to serve as a supportive device, either allowing the liver to regenerate upon acute liver failure, or to bridge the patient’s liver functions until a transplant is available.

Submitted by: admin
Hits: 55
Added: Tue Feb 02 2010